The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella.
about
Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differTyphoid fever: "you can't hit what you can't see"Helicobacter and salmonella persistent infection strategiesSalmonella as a vaccine delivery vehicleExpression and function of S100A8/A9 (calprotectin) in human typhoid fever and the murine Salmonella modelThe Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxisTyphoidal and non-typhoidal Salmonella infections in Africa.Molecular insights into farm animal and zoonotic Salmonella infections.Salmonella enterica Serovar Typhi conceals the invasion-associated type three secretion system from the innate immune system by gene regulation.The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts.Salmonella enterica serovar Typhi impairs CD4 T cell responses by reducing antigen availabilityBacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9Contrasting persistence strategies in Salmonella and MycobacteriumA rapid change in virulence gene expression during the transition from the intestinal lumen into tissue promotes systemic dissemination of Salmonella.Immunity to intestinal pathogens: lessons learned from SalmonellaTaming the elephant: Salmonella biology, pathogenesis, and prevention.Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.A Salmonella Typhimurium-Typhi genomic chimera: a model to study Vi polysaccharide capsule function in vivo.Host response transcriptional profiling reveals extracellular components and ABC (ATP-binding cassette) transporters gene enrichment in typhoid fever-infected Nigerian children.Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection.Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection.Host-pathogen interaction in invasive Salmonellosis.Lipopolysaccharides belonging to different Salmonella serovars are differentially capable of activating Toll-like receptor 4.In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoterThe polysaccharide capsule of Streptococcus pneumonia partially impedes MyD88-mediated immunity during pneumonia in miceFeverlike Temperature is a Virulence Regulatory Cue Controlling the Motility and Host Cell Entry of Typhoidal SalmonellaGenetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma.Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa.Biofilm-associated bacterial amyloids dampen inflammation in the gut: oral treatment with curli fibres reduces the severity of hapten-induced colitis in miceThe capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.Differences in Host Cell Invasion and Salmonella Pathogenicity Island 1 Expression between Salmonella enterica Serovar Paratyphi A and Nontyphoidal S. TyphimuriumLoss of very-long O-antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi.Humoral immunity against capsule polysaccharide protects the host from magA+ Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling.Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infectionThe capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanismHost specificity of bacterial pathogens.Salmonella Extracellular Matrix Components Influence Biofilm Formation and Gallbladder Colonization.Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilmsLive Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity
P2860
Q24561569-314FE1FD-B4C2-4A94-9C4B-0222A1A50CFFQ26860755-112F0EDB-10FA-41DB-A1BC-31A700DFEA40Q26997068-DC07B40D-FDA7-46FD-8A2C-5851DB9BDCB2Q27011946-22CD5765-DDBC-48C4-9D75-057C45B7C8AFQ27304521-4EC49CBC-AA9A-441C-912F-695D3D77044BQ27324387-4E9DCA56-5E05-46D1-97DC-BAC992BB11BAQ30248288-917C1A55-5640-4AD9-882A-08E31ED932E3Q31079248-FCA06037-4479-4402-BAD2-C6055A368193Q31172548-1893688E-3F75-4E5F-927C-723AE02AA54EQ33523176-9265A3A4-FE4E-4D5F-AAA9-E20A70CA5FF6Q33603033-2FBF8F7F-9A75-4FDC-BDBF-C71141F1DE30Q33606019-070662D5-2412-42E4-A513-AF06B0F8969EQ33654036-758523CB-AA3E-4B01-89B9-27A9478AB075Q33680498-F61FFECB-FD67-480A-A924-CD152B3928A6Q33788711-6A012577-558A-4327-BCFE-9C5BF22AD7E9Q33877264-7F099060-5A39-4A36-9ED1-890570588778Q33901610-D2C48ADB-3F5B-4423-8F7B-1E82ABCE3799Q33987406-43A66BD1-97D6-49AF-B27B-CBB5D6FE4C70Q34018436-6629963E-9068-4A89-B0F9-1891FAE3D3B9Q34100373-2BA62699-DB6A-4FED-A79E-D887F02A08B1Q34116324-06F04F76-EBC6-4BEE-B572-AB6AB9515BACQ34440638-7158C7C9-AD46-4DAE-87B4-3DBC65D0B5B7Q34596093-49551C36-8111-45B1-A326-BA0D67B9DC02Q35075822-705B8181-7C03-4680-9C52-A840A3437BBDQ35564597-E5305863-44E6-4C49-BF6B-B41760458D02Q35974398-52E9A57E-6DEB-4EAD-B48D-9199A73267C9Q35984126-7317DB05-474E-47BF-BA6C-5959B50E9901Q36396853-706FBAF8-A617-447E-8B4A-A8455005C3B9Q36539870-7233B5C2-0DC4-4E6B-B6A7-6D8809B9DC92Q36708987-AA5977BE-4C6D-4103-9D75-8968FDE7390EQ36728030-C7DFDC00-9009-492C-A8BF-A9759BF2D059Q37074488-622F0523-56A5-4564-ABA8-F8325263AB09Q37075445-0EF7991D-666B-48D8-80E1-B5F9FDED8A4FQ37191428-4DD6C999-C5CA-4666-8A73-58724F6B21B9Q37256566-B18A2D96-4BC7-4CBE-93C1-FA61D49DA1F2Q37340368-0A6EB843-2B75-4767-894D-95CFB5D46DE7Q37345933-43BF36EB-4F8F-4820-835C-23521A828702Q37349670-B2D7EB59-8958-4A90-AED3-DB944CE766B2Q37405926-0CC83B84-6AE1-4ADB-AA51-94E72A59ADC2Q37429384-2E398262-894D-4AE5-AB07-99A3B2D9F2BC
P2860
The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella.
@en
type
label
The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella.
@en
prefLabel
The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella.
@en
P2860
P50
P1476
The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella
@en
P2093
Cagla Tükel
R Paul Wilson
P2860
P304
P356
10.1111/J.1462-5822.2007.01090.X
P577
2007-11-22T00:00:00Z